Skip to Content

N 739 150 (Mexiletine 150 mg)

Pill imprint N 739 150 has been identified as Mexiletine hydrochloride 150 mg.

Mexiletine is used in the treatment of ventricular tachycardia; diabetic peripheral neuropathy; myotonia congenita; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150 Front
Mexiletine hydrochloride 150 mg N 739 150 Back
Mexiletine hydrochloride
N 739 150
150 mg
Tan / Orange
18.00 mm
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
magnesium stearate
corn starch
FD&C Yellow No. 6
titanium dioxide
D&C Red No. 28
FD&C Blue No. 1
ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Red No. 40
isopropyl alcohol
butyl alcohol
propylene glycol

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0624 AvKare, Inc.
55045-3634 Dispensing Solutions Inc. (repackager)
49999-0916 Lake Erie Medical and Surgical Supply (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.